What a Trip: The Rick Doblin Story

What a Trip: The Rick Doblin Story, formerly known as Prescription X: The Rick Doblin Story, is an in-production crowdfunded documentary film about Rick Doblin and his efforts towards legalization of psychedelics and MDMA over the course of 50 years.^[1]^[2]^[3]^[4]^[5] It is being directed by filmmaker Nirvan Mullick and its executive producer is Darren Aronofsky.^[1]^[4]^[5] A trailer for the film was shown at the Multidisciplinary Association for Psychedelic Studies (MAPS)'s Psychedelic Science 2023 conference.^[2]^[3] Originally planned to be released following FDA approval of MDMA-assisted therapy for treatment of post-traumatic stress disorder (PTSD), the film is now expected to be completed by the end of 2027.

Directed byNirvan Mullick

Story byVickie Curtis

Produced byDarren Aronofsky, Dream Mullick

StarringRick Doblin, others

Quick facts Directed by, Story by ...

What a Trip: The Rick Doblin Story
Poster for the trailer of the film shown at Psychedelic Science 2023.
Directed by	Nirvan Mullick
Story by	Vickie Curtis
Produced by	Darren Aronofsky, Dream Mullick
Starring	Rick Doblin, others
Cinematography	Jeffrey Schneider
Language	English

References

[1]
Heyward, Giulia (15 July 2019). "New Documentary Will Cover How Sarasota Influenced the Future of Trauma Therapy". Sarasota Magazine. Retrieved 18 August 2026.
[2]
Jennings, Lindsey; Steinig, Nickolas (11 June 2025). "Open Circle Media: The Collaborative Creation of a Media Production Enterprise". JBC Commons. Retrieved 18 August 2026. The project Prescription X follows the colorful life and work of Doblin, a pioneer in psychedelic psychotherapy research, who has an aspiration to legalize MDMA for therapeutic use. Doblin is a New College graduate holding both a Master's and Doctorate degree in Public Policy from Kennedy School of Government at Harvard University who I had originally met filming at an New College alumni event. The still-in-progress film is a deep reflection of his resilience and advocacy. Doblin's intertwined involvement and deep moments in his own personal life are also showcased; in the limited-release trailer [...]
[3]
Lucid News (25 June 2023). "Report: Final Round-up from MAPS Psychedelic Science 2023". Lucid News - Psychedelics. Retrieved 18 August 2026. The program presented a triumphant narrative arc, starting with a congratulatory summary of the week's events, music, and the crowdfunding trailer for the Rick Doblin documentary "Prescription X."
[4]
"Psychedelic Research panel brings legendary alums to campus to talk harm reduction and New College lore". The Catalyst. 19 April 2022. Retrieved 18 August 2026. And finally, while Mullick does not have the same experience in psychedelic research as the other panelists, he is directing and producing a documentary—Prescription X: A Rick Doblin Story, clips of which were shown at the panel.
[5]
"About". What a Trip. Retrieved 18 August 2026. The Story: What a Trip follows Dr. Rick Doblin, the colorful founder of MAPS, on his half-century odyssey to legalize psychedelics for therapy. Filmmaker Nirvan Mullick, who has never tried psychedelics, spends over a decade intimately following Doblin's tireless efforts to make MDMA assisted therapy legal. Nirvan and Rick's stories converge as Doblin's unlikely psychedelic dream confronts reality.

What a Trip: The Rick Doblin Story

See also

References

External links

Related Articles

Timelines

Top Qs

Fact Checks